rs886042057

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PS3PP3_StrongPP5_Very_Strong

The NM_000153.4(GALC):​c.195G>C​(p.Gly65Gly) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000138 in 1,520,264 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000964060: Studies have shown that this variant results in abnormal splicing, and produces a non-functional protein and/or introduces a premature termination codon (PMID:8940268)." and additional evidence is available in ClinVar. Synonymous variant affecting the same amino acid position (i.e. G65G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000098 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000044 ( 0 hom. )

Consequence

GALC
NM_000153.4 splice_region, synonymous

Scores

3
Splicing: ADA: 0.9999
2

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:7

Conservation

PhyloP100: 3.10

Publications

4 publications found
Variant links:
Genes affected
GALC (HGNC:4115): (galactosylceramidase) This gene encodes a lysosomal protein which hydrolyzes the galactose ester bonds of galactosylceramide, galactosylsphingosine, lactosylceramide, and monogalactosyldiglyceride. Mutations in this gene have been associated with Krabbe disease, also known as globoid cell leukodystrophy. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
GALC Gene-Disease associations (from GenCC):
  • Krabbe disease
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, ClinGen, Laboratory for Molecular Medicine, G2P, Labcorp Genetics (formerly Invitae), Myriad Women's Health

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000153.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV000964060: Studies have shown that this variant results in abnormal splicing, and produces a non-functional protein and/or introduces a premature termination codon (PMID: 8940268).; SCV001443768: Functional studies support a damaging effect of this variant on splicing (PMID: 8940268).; SCV002819635: The variant was absent in 125252 control chromosomes. c.195G>C has been reported in the literature in individuals affected with slowly progressive/late onset Krabbe Disease (example, De Gasperi_1996, Bernardini_1997, Debs_2013). These data indicate that the variant is likely to be associated with disease. Internal structural analysis indicates that this variant affects mRNA splicing resulting in first 126 bases of intron 1 inserted in-frame between nucleotides 195 and 196 (legacy nucleotides 147 and 148) (exactly at the junction of exons 1 and 2), because of the activation of a cryptic splice site (De Gasperi_1996).
PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF. Scorers claiming Uncertain: max_spliceai. No scorers claiming Benign.
PP5
Variant 14-87992970-C-G is Pathogenic according to our data. Variant chr14-87992970-C-G is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 280959.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000153.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GALC
NM_000153.4
MANE Select
c.195G>Cp.Gly65Gly
splice_region synonymous
Exon 1 of 17NP_000144.2P54803-1
GALC
NM_001424072.1
c.-76G>C
splice_region
Exon 1 of 18NP_001411001.1
GALC
NM_001424075.1
c.-242G>C
splice_region
Exon 1 of 18NP_001411004.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GALC
ENST00000261304.7
TSL:1 MANE Select
c.195G>Cp.Gly65Gly
splice_region synonymous
Exon 1 of 17ENSP00000261304.2P54803-1
GALC
ENST00000622264.4
TSL:1
c.183G>Cp.Gly61Gly
splice_region synonymous
Exon 1 of 10ENSP00000480649.1A0A087WX10
GALC
ENST00000474294.6
TSL:1
n.185G>C
splice_region non_coding_transcript_exon
Exon 1 of 10

Frequencies

GnomAD3 genomes
AF:
0.0000986
AC:
15
AN:
152186
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000362
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000439
AC:
6
AN:
1367970
Hom.:
0
Cov.:
33
AF XY:
0.00000444
AC XY:
3
AN XY:
676338
show subpopulations
African (AFR)
AF:
0.000216
AC:
6
AN:
27802
American (AMR)
AF:
0.00
AC:
0
AN:
35918
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24042
East Asian (EAS)
AF:
0.00
AC:
0
AN:
32274
South Asian (SAS)
AF:
0.00
AC:
0
AN:
77270
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
34792
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3992
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1075202
Other (OTH)
AF:
0.00
AC:
0
AN:
56678
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000985
AC:
15
AN:
152294
Hom.:
0
Cov.:
33
AF XY:
0.0000671
AC XY:
5
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.000361
AC:
15
AN:
41576
American (AMR)
AF:
0.00
AC:
0
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68000
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000117

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
4
-
-
Galactosylceramide beta-galactosidase deficiency (4)
3
-
-
not provided (3)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.36
CADD
Benign
22
DANN
Benign
0.90
PhyloP100
3.1
PromoterAI
-0.17
Neutral
Mutation Taster
=9/91
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.99
SpliceAI score (max)
0.49
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.49
Position offset: 0

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs886042057;
hg19: chr14-88459314;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.